LifeStance Health Group, Inc. (LFST)
As of Sep 19, 2026, LifeStance Health Group, Inc. (LFST) scores 3.4/10 on AlphaStocks' five-model composite, #151 of 168 Health Care stocks.
Health Care / Health Care Services
S&P SmallCap 600$12.57
Scores poorly across most models. Proceed with caution.
Weak
Score based on 4 of 5 models — moderate confidence
Data as of Sep 19, 2026
Is LifeStance Health Group, Inc. a Good Investment in 2026?
LifeStance Health Group, Inc. (LFST) scores 3.4 out of 10 on AlphaStocks' composite model, earning a Weak rating. The Piotroski model rates LifeStance Health Group, Inc. as Strong (7/9). However, the Greenblatt Magic Formula model rates it Caution — Earnings yield 0.6% · ROC 7%. LifeStance Health Group, Inc. ranks #151 out of 168 stocks in the Health Care sector.
This summary is algorithmically generated and is not financial advice.
Key Metrics
Valuation
Trades at 509x earnings — significantly above sector median of 30x. Premium reflects market growth expectations.
Fair value estimate not available for this stock.
5-Model Analysis
Each model evaluates this stock from a different angle. Combined, they form the composite score above.
Piotroski
Strong
7/9
Buffett
Caution
Business quality & competitive moat
Graham
Caution
Significantly above fair value
Lynch
Limited Data
Growth rate vs price (PEG)
Greenblatt
Caution
Earnings yield 0.6% · ROC 7%
Frequently Asked Questions
Is LifeStance Health Group, Inc. (LFST) a good investment?
What is LifeStance Health Group, Inc.'s Piotroski F-Score?
Is LFST overvalued or undervalued?
How does LFST compare to other Health Care stocks?
What do investment models say about LFST?
Similar Stocks
Compare LFST with
Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer